Adjusted Prices Review
Published: 01/07/21
As a part of our continuing discussions with the Scottish Government and Public Health Scotland, we regularly raise lines of concern and work to secure adjusted prices for these.
Following an ask from the Scottish Government to review the Adjusted Prices, you will see that there have been a significant number of lines that have been removed from the website as of the 1st July 2021, as it has been agreed that these items have stabilised in price and availability. We have detailed for you what the prices are as of July 2021 and where applicable what the price has changed to from the previous month. Where there is no previous price or movement this is due to the price remaining the same.
You can review the list of current Adjusted Prices on the website with their revised prices as of the 1st of July. We ask you to please continue to use our Shortages Reporter to report any lines that are of concern to us in order to monitor items not available at Drug Tariff price or lines not available, allowing us to continue to negotiate with Public Health Scotland and raise any issues.
If you have any questions about the July 2021 Drug Tariff please do not hesitate to contact the Pharmacy Services team on 0131 466 3540 or email pharmacy.services@cps.scot
The new updated version of Part 7 is now available for October 2024. In this month there are four additions and two deletions from the drug tariff we wanted to make you aware of.
This Circular advises contractors of a balancing payment relating to the 2023/24 global sum, which will be made along with September’s payments.
The new updated version of Part 7 is now available for September 2024. In this month there is one addition and one deletion from the drug tariff we wanted to make you aware of.
Due to the day on which the 1st September falls this year, we will publish the September edition of Part 7 on the website slightly later than usual, week beginning Monday 2nd September 2024.
As a part of our work with the Scottish Government and Public Health Scotland, we regularly raise lines of concern and work to secure adjusted prices for these. We also work with them regularly to review lines which have now stabilised and remove these as appropriate.
Due to the day on which the 1st June falls this year, we will publish the June edition of Part 7 on the website slightly later than usual, on Monday 3rd May 2024.
This circular advises community pharmacy contractors and NHS Boards on the amendments to the Drug Tariff Part 11 clawback scale.
The new updated version of Part 7 is now available for May 2024. In this month there are three deletions to Part 7S of the drug tariff we wanted to make you aware of.
We have been advised that the May 2024 edition of Part 7 will be slightly delayed this month.
The annual reset of the Drug Tariff has now been undertaken by Public Health Scotland. This is where they balance the value of the tariff by modulating molecules up or down with a view to delivering the same overall value against volume and having outlier prices brought in line as part of the process.
Based on evidence, there are several lines that have stabilised which you can view here with their revised price for April 2024. These are no longer treated as Adjusted Prices; however, we will continue to monitor these lines, so we ask you to please continue to use our Shortages Reporter to report any that are of concern.
Due to continued discussions with Public Health Scotland Part 7 of the Scottish drug tariff for April 2024 will not likely be published until early next week once all work is complete and agreed.
Please note, due to the day on which the 1st April falls this year, we will publish the April edition of Part 7 on the website slightly later than usual, early next week.
The new updated version of Part 7 is now available for March 2024. In this month there are several additions we wanted to make you aware of.
There’s a 10 minute survey where you can give your views on ways to improve the production, organisation and delivery of the information.
Following the release of PCA (P)(2023) 46 Amendments to the Drug Tariff Part 11 Discount Clawback Scale, it was brought to our attention that the annex within the circular had a number of anomalies within of negative percentages.
PCA(P)(2023)46 - Pharmaceutical Services Amendments To The Drug Tariff Part 11 Discount Clawback Scale
This circular advises of changes to the Drug Tariff with respect to remuneration arrangements for the dispensing pool month of July.
We would like to signpost everyone to this part of the Scottish Drug Tariff.
This Circular advises of changes to the Scottish Drug Tariff effective from 1 May 2023 in respect of reimbursement of costs borne by community pharmacy contractors when dispensing NHS prescriptions for part 7 medicines.
This Circular advises of changes in the Drug Tariff effective for dispensing 1 May 2023 in respect of reimbursement of costs borne by community pharmacy contractors when dispensing NHS prescriptions for specialist preparations and imported unlicensed medicines listed in Part 7S.
This circular advises pharmacy contractors and NHS Boards on amendments to the Drug Tariff Part 11 clawback scale.
This circular advises of the introduction of an advance cash payment to be paid to eligible community pharmacies, dispensing doctor practices and DAC suppliers in January 2023.
This circular advises of changes to the Drug Tariff with respect to remuneration arrangements for the dispensing pool month of March 2022. This temporary payment adjustment is required to regulate the delivery of the remuneration Global Sum for 2021/22.
This circular sets out to community pharmacy contractors and NHS Boards the details of the community pharmacy funding arrangement 2022-23. This forms part of the 3-year settlement introduced in April 2020.
This circular advises community pharmacy contractors and NHS Boards on the amendments to the Drug Tariff Part 11 clawback scale.
Please note as of the 1st December 2021, Senna 7.5mg/5ml oral solution will be changed to Sennoside 7.5mg/5ml oral solution in Part 7b of the Scottish Drug Tariff.
There are now licensed versions of Venlafaxine Oral Suspension 37.5mg/5ml and 75mg/5ml 150ml packs available
With the Revised List of Approved List Products (PCA (P) (2021) 14) Circular, from 1st October 2021
Digital Communications Officer
This circular sets out to community pharmacy contractors the details of the community pharmacy funding arrangement for 2024/25.